The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
The dawning era of polymer therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Biodegradable, Elastic Shape-Memory Polymers for Potential Biomedical Applications
Lendlein, A., & Langer, R. (2002) · Science · doi:10.1126/science.1066102 · Cited by 2,146
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Carbohydrate-Specific Receptors of the Liver
Ashwell, G., & Harford, J. (1982) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.51.070182.002531 · Cited by 1,914
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,898
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,604
Clinical translation of angiogenesis inhibitors
Kerbel, R., & Folkman, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc905 · Cited by 1,517
Dendrimers and Other Dendritic Polymers
(2001) · Wiley eBooks · doi:10.1002/0470845821 · Cited by 1,429
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Gene Therapy Progress and Prospects: Nonviral vectors
Niidome, T., & Huang, L. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301923 · Cited by 963
Block copolymer micelles as vehicles for drug delivery
Kazunori, K., Glenn S., K., Masayuki, Y., Teruo, O., & Yasuhisa, S. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90172-2 · Cited by 877
Dendrimers and other dendritic polymers
Fréchet, J. M. J., & Tomalia, D. A. (2001) · Cited by 873
Effective drug delivery by PEGylated drug conjugates
Greenwald, R. B., Choe, Y. H., McGuire, J., & Conover, C. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00180-1 · Cited by 869
The emerging field of nanotube biotechnology
Martin, C. R., & Kohli, P. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd988 · Cited by 791
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Different behavior of branched and linear polyethylenimine for gene deliveryin vitro andin vivo
Wightman, L., Kircheis, R., R�ssler, V., Carotta, S., Ruzicka, R., Kursa, M., & Wagner, E. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.187 · Cited by 697
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Self-citationDevelopment of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Kopecek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00075-8 · Cited by 562
Therapeutic antibodies for human diseases at the dawn of the twenty-first century
Brekke, O. H., & Sandlie, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd984 · Cited by 550
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Biological applications of dendrimers
Cloninger, M. J. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00400-3 · Cited by 516
Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini
Putnam, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031577698 · Cited by 510
Drug-polymer conjugates: potential for improved chemotherapy
Duncan, R. (1992) · Anti-Cancer Drugs · doi:10.1097/00001813-199206000-00001 · Cited by 444
Self-citationSeymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Self-citationHepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
The uses and properties of PEG-linked proteins.
Delgado, C., Francis, G. E., & Fisher, D. (1992) · PubMed · Cited by 420
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
The next frontier of molecular medicine: Delivery of therapeutics
Jain, R. K. (1998) · Nature Medicine · doi:10.1038/nm0698-655 · Cited by 407
Therapeutic antibody fragments with prolonged in vivo half-lives
Chapman, A. P., Antoniw, P., Spitali, M., West, S., Stephens, S., & King, D. J. (1999) · Nature Biotechnology · doi:10.1038/11717 · Cited by 350
Kircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rössler, V, Kursa, M., & Wagner, E. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301351 · Cited by 350
Preclinical safety evaluation of biotechnology-derived pharmaceuticals
Cavagnaro, J. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd822 · Cited by 340
Etrych, T., Jelı́nková, M., Řı́hová, B., & Ulbrich, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00281-4 · Cited by 340
Li, C., Yu, D. F., Newman, R. A., Cabral, F., Stephens, L. C., Hunter, N. R., Milas, L., & Wallace, S. (1998) · PubMed · Cited by 340
Sigal, G. B., Mammen, M., Dahmann, G., & Whitesides, G. M. (1996) · Journal of the American Chemical Society · doi:10.1021/ja953729u · Cited by 338
Seymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Self-citationGillies, E. R., & Fréchet, J. M. J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja028100n · Cited by 328
Soluble synthetic polymers as potential drug carriers
Duncan, R., & Kopeček, J. (1984) · Advances in Polymer Science · doi:10.1007/3-540-12796-8_10 · Cited by 318
Self-citationPolymeric Antitumor Agents on a Molecular and on a Cellular Level?
Gros, L., Ringsdorf, H., & Schupp, H. (1981) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198103051 · Cited by 318
Mono-N-terminal poly(ethylene glycol)–protein conjugates
Kinstler, O., Molineux, G., Treuheit, M., Ladd, D., & Gegg, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00023-6 · Cited by 306
Slatopolsky, E. A., Burke, S. K., & Dillon, M. A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00240.x · Cited by 302
Stiriba, S.-E., Kautz, H., & Frey, H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026835m · Cited by 302
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Ferber, D. (2001) · Science · doi:10.1126/science.294.5547.1638 · Cited by 296
Masayuki, Y., Mizue, M., Noriko, Y., Teruo, O., Yasuhisa, S., Kazunori, K., & Shohei, I. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90139-k · Cited by 290
Fréchet, J. M. J., Hawker, C. J., Gitsov, I., & Leon, J. W. (1996) · Journal of Macromolecular Science, Part A · doi:10.1080/10601329608014916 · Cited by 287
Iwai, K., Maeda, H., & Konno, T. (1984) · PubMed · Cited by 284
Star and Hyperbranched Polymers
Kobayashi, S., & Mishra, M. (1999) · Medical Entomology and Zoology · Cited by 281
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Davis, F. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00021-2 · Cited by 278
The therapeutic value of poly(ethylene glycol)-modified proteins
Nucci, M. L., Shorr, R., & Abuchowski, A. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90037-d · Cited by 276
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00027-6 · Cited by 271
Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials
Alakhov, V., Klinski, E., Li, S., Pietrzynski, G., Venne, A., Batrakova, E., Bronitch, T., & Kabanov, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00064-8 · Cited by 266
Brunner, S., Fürtbauer, E., Sauer, T., Kursa, M., & Wagner, E. (2002) · Molecular Therapy · doi:10.1006/mthe.2001.0509 · Cited by 244
Polyethylene glycol-conjugated pharmaceutical proteins
Bailon, P., & Berthold, W. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00086-8 · Cited by 243
Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
Rajender Reddy, K., Modi, M. W., & Pedder, S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00028-5 · Cited by 241
Introduction and overview of peptide and protein pegylation
(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235
Wiwattanapatapee, R., Carreño-Gómez, B., Malik, N., & Duncan, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007587523543 · Cited by 234
Self-citationBatrakova, E., Dorodnych, T., Klinskii, E., Kliushnenkova, E., Shemchukova, O., Goncharova, O., Arjakov, S., Alakhov, V., & Kabanov, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.587 · Cited by 228
Gene transfer with lipospermines and polyethylenimines
Remy, J.-S., Abdallah, B., Zanta, M. A., Boussif, O., Behr, J.-P., & Demeneix, B. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00109-9 · Cited by 227
The clinical efficacy of poly(ethylene glycol)-modified proteins
Fuertges, F., & Abuchowski, A. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90127-f · Cited by 226
Poly(amido-amine)s: Biomedical Applications
Ferruti, P., Marchisio, M. A., & Duncan, R. (2002) · Macromolecular Rapid Communications · doi:10.1002/1521-3927(20020401)23:5/6<332::aid-marc332>3.0.co;2-i · Cited by 221
Self-citationLevy, Y., Hershfield, M. S., Fernandez-Mejia, C., Polmar, S. H., Scudiery, D., Berger, M., & Sorensen, R. U. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80271-3 · Cited by 215
Stabilization of Substances in Circulation
Monfardini, C., & Veronese, F. M. (1998) · Bioconjugate Chemistry · doi:10.1021/bc970184f · Cited by 213
Wu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212
Self-assembling complexes for gene delivery : from laboratory to clinical trial
Kabanov, A. V., Felgner, P. L., & Seymour, L. W. (1998) · Cited by 198
Duncan, R., Gac-Breton, S., Keane, R., Musila, R., Sat, Y. N., Satchi, R., & Searle, F. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00328-5 · Cited by 195
Self-citationDuncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopeček, J. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841005 · Cited by 193
Self-citationBiocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin
Rihova, B., Bilej, M., Vetvicka, V., Ulbrich, K., Strohalm, J., Kopecek, J., & Duncan, R. (1989) · Biomaterials · doi:10.1016/0142-9612(89)90075-6 · Cited by 192
Self-citationEnzymatic procedure for site-specific pegylation of proteins
Sato, H. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00024-8 · Cited by 187
Preclinical evaluation of polymer-bound doxorubicin
Duncan, R., Seymour, L. W., O'Hare, K. B., Flanagan, P. A., Wedge, S., Hume, I. C., Ulbrich, K., Strohalm, J., Subr, V., Spreafico, F., et al. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90088-9 · Cited by 187
Self-citationGianasi, E., Wasil, M., Evagorou, E. G., Keddle, A., Wilson, G., & Duncan, R. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00030-1 · Cited by 186
Self-citationJulyan, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00124-2 · Cited by 180
Fundamentals Of Polymer Science
Shea, J. (1998) · IEEE Electrical Insulation Magazine · doi:10.1109/mei.1998.714645 · Cited by 166
Polymer Conjugates: Pharmacokinetic Considerations for Design and Development
Duncan, R., & Spreafico, F. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00004 · Cited by 164
Self-citationSeymour, L., Ulbrich, K., Steyger, P., Brereton, M., Subr, V, Strohalm, J., & Duncan, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.363 · Cited by 164
Self-citationŘíhová, B. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00404-8 · Cited by 162
Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site
Goodson, R. J., & Katre, N. V. (1990) · Nature Biotechnology · doi:10.1038/nbt0490-343 · Cited by 159
Jatzkewitz, H. (1955) · Zeitschrift für Naturforschung B · doi:10.1515/znb-1955-0106 · Cited by 158
Merdan, T., Kunath, K., Fischer, D., Kopec̆ek, J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1014212630566 · Cited by 155
Nori, A., Jensen, K. D., Tijerina, M., Kopečková, P., & Kopec̆ek, J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0255900 · Cited by 145
Robinson, B. V., Sullivan, F. M., Borzelleca, J. F., & Schwartz, S. L. (2018) · Routledge eBooks · doi:10.1201/9780203741672 · Cited by 141
Rejmanová, P., Kopec̆ek, J., Duncan, R., & Lloyd, J. B. (1985) · Biomaterials · doi:10.1016/0142-9612(85)90037-7 · Cited by 138
Self-citationPDEPT: polymer-directed enzyme prodrug therapy
Satchi, R., Connors, T. A., & Duncan, R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2026 · Cited by 132
Self-citationDUNCAN, R., Seymour, L. W., Scarlett, L., LLOYD, J., Rejmanová, P., & Kopeček, J. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90120-0 · Cited by 130
Self-citationBiologically Active Synthetic Polymers
Breslow, D. S. (1976) · Pure and Applied Chemistry · doi:10.1351/pac197646020103 · Cited by 128
Sabbatini, P. J., Aghajanian, C. A., Dizon, D. S., Anderson, S., Dupont, J., Brown, J. V., Peters, W. A., Jacobs, A. D., Mehdi, A., Rivkin, S. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.043 · Cited by 125
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
Schoemaker, N. E., van Kesteren, C., Rosing, H., Jansen, S., Swart, M., Lieverst, J. A., Fraier, D., Breda, M., Pellizzoni, C., Spinelli, R., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600516 · Cited by 122
Tomlinson, R. D., Klee, M., Garrett, S., Heller, J., Duncan, R., & Brocchini, S. (2001) · Macromolecules · doi:10.1021/ma0108867 · Cited by 118
Self-citationPegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
Bukowski, R. M., Ernstoff, M. S., Gore, M. E., Nemunaitis, J. J., Amato, R. J., Gupta, S. K., & Tendler, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.051 · Cited by 117
Sprincl, L., Exner, J., Stĕrba, O., & Kopeček, J. (1976) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820100612 · Cited by 107
Fulfilling the promise: drug discovery in the post-genomic era
Chanda, S. K., & Caldwell, J. S. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02595-3 · Cited by 104
Stayton, P. S., Hoffman, A. S., Murthy, N., Lackey, C. A., Cheung, C., Tan, P., Klumb, L. A., Chilkoti, A., Wilbur, F. S., & Press, O. W. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00236-9 · Cited by 103
Li, C., Shi, K., Wu, Q., Tansey, W., Hunter, N. R., Buchmiller, L., Milas, L., Charnsangavej, C., & Wallace, S. (2000) · PubMed · Cited by 102
Poly(ethylene glycol) Multiblock Copolymer as a Carrier of Anti-Cancer Drug Doxorubicin
Pechar, M., Ulbrich, K., Šubr, V., Seymour, L. W., & Schacht, E. H. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990092l · Cited by 97
Satchi‐Fainaro, R., Hailu, H., Davies, J. W., Summerford, C., & Duncan, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020091k · Cited by 94
Self-citationKobayashi, H., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Konishi, J., Togashi, K., & Brechbiel, M. W. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10025 · Cited by 88
Polyethylene Glycol Modification: Relevance of Improved Methodology to Tumour Targeting
Francis, G. E., Delgado, C., Fisher, D., Malik, F., & Agrawal, A. K. (1996) · Journal of drug targeting · doi:10.3109/10611869608996824 · Cited by 82
Thomson, A. H., Vasey, P. A., Murray, L. S., Cassidy, J., Fraier, D., Frigerio, E., & Twelves, C. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690657 · Cited by 81
Synthetic biologically active polymers
Donaruma, L. G. (1975) · Progress in Polymer Science · doi:10.1016/0079-6700(75)90002-7 · Cited by 81
Yeung, T. K., Hopewell, J. W., Simmonds, R. H., Seymour, L. W., Duncan, R., Bellini, O., Grandi, M., Spreafico, F., Strohalm, J., & Ulbrich, K. (1991) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00687318 · Cited by 77
Self-citationPreclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1)
Duncan, R., Coatsworth, J. K., & Burtles, S. S. (1998) · Human & Experimental Toxicology · doi:10.1177/096032719801700204 · Cited by 76
Self-citationCopolymer 1: from basic research to clinical application
Teitelbaum, D., Arnon, R., & Sela, M. (1997) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000576 · Cited by 75
Gianasi, E., Buckley, R. G., Latigo, J. R., Wasil, M., & Duncan, R. (2002) · Journal of drug targeting · doi:10.1080/1061186021000072456 · Cited by 64
Self-citationHandbook of Anticancer Drug Development
Budman, D. R., Calvert, H., Rowinsky, E. K., & Hill, B. T. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200411000-00011 · Cited by 55
Adverse effects of gene therapy: gene therapy can cause leukaemia: no shock, mild horror but a probe
Gore, M. E. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301946 · Cited by 53
Review : Synthetic Polymers with Intrinsic Anticancer Activity
Seymour, L. (1991) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159100600205 · Cited by 53
Stafford, M. K., Cain, D., Rosenstein, I. J. M., Fontaine, E. A., McClure, M. O., Flanagan, A. M., Smith, J. R., TAYLOR‐ROBINSON, D., Weber, J., & Kitchen, V. S. (1997) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199703010-00003 · Cited by 46
The further evolution of biotech
Nagle, T., Berg, C., Nassr, R., & Pang, K. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd989 · Cited by 42
Dautzenberg, H., Zintchenko, A., Koňák, Č., et al. (2001) · Langmuir · doi:10.1021/la001779t · Cited by 41
Ferruti, P., Knobloch, S., Ranucci, E., Duncan, R., & Gianasi, E. (1998) · Macromolecular Chemistry and Physics · Cited by 41
Self-citationImmunological problems of polymer-bound drugs.
Rihova, B., & Říha, I. (1985) · PubMed · Cited by 41
Maeda, H., & Konno, T. (1997) · Springer eBooks · doi:10.1007/978-4-431-66914-2_12 · Cited by 35
Shaunak, S., Thornton, M., John, S., Teo, I. A., Peers, E. M., Mason, P. D., Krausz, T. N., & Davies, D. S. (1998) · AIDS · doi:10.1097/00002030-199804000-00009 · Cited by 32
Chaves, F., Calvo, J. C., Carvajal, C., Monroy, Z. J. R., Ramírez, L., Pinto, M., Trujillo, M., Guzmán, F., & Patarroyo, M. E. (2001) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2001.00921.x · Cited by 28
Regelson, W. (1986) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391158600100109 · Cited by 26
Targeting Chemotherapy of Hepatocellular Carcinoma
Konno, T., & Maeda, H. (1987) · Springer eBooks · doi:10.1007/978-4-431-68349-0_27 · Cited by 22
Boddy, A., Todd, R., Verrill, M., Sludden, J., Fishwick, K., Robson, L., Cassidy, J., Bisset, D., Garzone, P., & Calvert, A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80747-x · Cited by 18
Biocompatibility of Biopolymers
Volfova, I., Řı́hová, B., Větvička, V., Rossmann, P., & Ulbrich, K. (1992) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159200700205 · Cited by 16
Anti-Kaposi’s Sarcoma and Antiangiogenic Activities of Sulfated Dextrins
Thornton, M., Barkley, L. R., Mason, J. C., & Shaunak, S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2528 · Cited by 7
Cited by
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Metadata
- Authors
- Duncan, R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-05
- Volume
- 2
- Issue
- 5
- Pages
- 347-360
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2030855909
- Cited by
- 3,269
- References
- 126
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.